Evidence map›Paper›PMID 29018073›Full record

ArticleBMJ open2017

Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015-2016: a hospital-based test-negative case

Monika Kuliese, Ligita Jancoriene, Rita Grimalauskaite, Birute Zablockiene, Gyte Damuleviciene, Daiva Velyvyte, Vita Lesauskaite, Arvydas Ambrozaitis, Aukse Mickiene, Giedre Gefenaite

Abstract read
In one paragraph

Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monika KulieseDepartment of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ligita JancorieneClinic of Infectious, Chest Diseases, Dermatovenerology and Allergology, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Rita GrimalauskaiteDepartment of Geriatrics, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Birute ZablockieneClinic of Infectious, Chest Diseases, Dermatovenerology and Allergology, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Gyte DamulevicieneDepartment of Geriatrics, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Daiva VelyvyteDepartment of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Vita LesauskaiteDepartment of Geriatrics, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Arvydas AmbrozaitisClinic of Infectious, Chest Diseases, Dermatovenerology and Allergology, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Aukse MickieneDepartment of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Giedre GefenaiteDepartment of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA case-control study was conducted to assess seasonal influenza vaccine effectiveness (SIVE) during the 2015-2016 influenza season.

methodsA study was performed in three departments in Lithuania between 1 December 2015 and 1 May 2016. Data on demographic and clinical characteristics including influenza vaccination status were collected from the patients recommended to receive the seasonal influenza vaccine. Influenza virus infection was confirmed by multiplex reverse transcription polymerase chain reaction (RT-PCR) .

resultsNinety-one (56.4%) of the 163 included subjects were ≥65 years old. Fifteen (9.2%) subjects were vaccinated against influenza at least 2 weeks before the onset of influenza symptoms, 12 of them were ≥65 years old. Of the 72 (44.2%) influenza virus positive cases, 65 (39.9%) were confirmed with influenza A (including 50 cases of influenza A(H1N1)pdm09), eight (4.9%) were confirmed with influenza B and one was a co-infection. Unadjusted SIVE against any influenza, influenza type A and influenza A(H1N1)pdm09 was 57% (95% CI -41% to 87%), 52% (95% CI -57% to 85%) and 70% (95% CI -43% to 94%) respectively.

conclusionAlthough SIVE estimates were not statistically significant the point estimates suggest moderate effectiveness against influenza type A.

Indexed as

Influenza A virusInfluenza VaccinesSeasonsVaccinationAdolescentAdultAgedAged, 80 and overCase-Control StudiesFemaleHospitalsHumansInfluenza A Virus, H1N1 SubtypeInfluenza B virusInfluenza, HumanLithuaniaInfluenza Vaccineseffectivenessinfluenzainfluenza vaccinationlithuaniatest-negative case-control study

Identifiers

PMID29018073
PMCPMC5652622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.